Compensation to patient [Regulatives / Guidelines]

posted by Pharma_88 – India, 2025-01-22 14:02 (59 d 09:07 ago) – Posting: # 24344
Views: 804

Dear All,

For Bioequivalence study conducted on patients, do we need to provide financial compensation to patients for the participation i.e. Housing or blood loss for Pharmacokinetic evaluation? any guideline from DCGI/ICMR or any regulatory body?

Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,669 registered users;
23 visitors (0 registered, 23 guests [including 8 identified bots]).
Forum time: 23:09 CET (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5